Mountain Crest Acquisition II (Mountain Crest Acquisition II) Cash, Cash Equivalents, Marketable Securities : $0.03 Mil (As of Oct. 2020)

View and export this data going back to 2021. Start your Free Trial

What is Mountain Crest Acquisition II Cash, Cash Equivalents, Marketable Securities?

Mountain Crest Acquisition II's quarterly cash, cash equivalents, marketable securities stayed the same from . 20 ($0.00 Mil) to . 20 ($0.00 Mil) but then increased from . 20 ($0.00 Mil) to Oct. 2020 ($0.03 Mil).

Mountain Crest Acquisition II's annual cash, cash equivalents, marketable securities stayed the same from . 20 ($0.00 Mil) to . 20 ($0.00 Mil) but then increased from . 20 ($0.00 Mil) to Dec. 2020 ($0.03 Mil).

Mountain Crest Acquisition II Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Mountain Crest Acquisition II's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mountain Crest Acquisition II Cash, Cash Equivalents, Marketable Securities Chart

Mountain Crest Acquisition II Annual Data

Trend

Dec20

Cash, Cash Equivalents, Marketable Securities

0.03

Mountain Crest Acquisition II Semi-Annual Data
	Oct20
Cash, Cash Equivalents, Marketable Securities	0.03

Mountain Crest Acquisition II Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Mountain Crest Acquisition II (NAS:MCADU) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Mountain Crest Acquisition II Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Mountain Crest Acquisition II's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Mountain Crest Acquisition II (Mountain Crest Acquisition II) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Mountain Crest Acquisition Corp II (NAS:MCADU) » Definitions » Cash, Cash Equivalents, Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

311 West 43rd Street, 12th Floor, New York, NY, USA, 10036

Website

Mountain Crest Acquisition Corp II is a blank check company.

Executives

Frank Karbe	director, officer: See Remarks	C/O MYOVANT SCIENCES INC., 2000 SIERRA POINT PARKWAY, 9TH FLOOR, BRISBANE CA 94005
Elder Granger	director	5176 S. LEWISTON WAY, CENTENNIAL CO 80015
Richard H Carmona	director	1221 BROADWAY, OAKLAND CA 94612
Geoffrey M. Parker	director	15 RIORDAN PLACE, MENLO PARK CA 94025
Risa J Lavizzo-mourey	director	GE HEALTHCARE TECHNOLOGIES INC., 500 W. MONROE ST., CHICAGO IL 60661
Andrew J. Armanino	director	C/O CALIFORNIA BANCORP, 1300 CLAY STREET, FIFTH FLOOR, OAKLAND CA 94612
David P Perry	director, 10 percent owner, officer: See Remarks	1020 EAST MEADOW CIRCLE, PALO ALTO CA 94303
Suying Liu	director	311 WEST 43RD STREET, 12TH FLOOR, NEW YORK NY 10036
Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended	10 percent owner	548 MARKET STREET, #49404, SAN FRANCISCO CA 94104
David P. Perry 2015 Trust	10 percent owner	548 MARKET STREET, #49404, SAN FRANCISCO CA 94104
Mark A. Berman	officer: Chief Medical Officer	548 MARKET STREET, #49404, SAN FRANCISCO CA 94104
Kevin J Appelbaum	director, 10 percent owner, officer: Chief Executive Officer	4160 DUBLIN BLVD., SUITE 200, DUBLIN CA 94568
Mark Heinen	officer: See Remarks	548 MARKET STREET, #49404, SAN FRANCISCO CA 94104
Justin Zamirowski	officer: Chief Commercial Officer	548 MARKET STREET, #49404, SAN FRANCISCO CA 94104
Kristin Wynholds	officer: Chief Product Officer	548 MARKET STREET, #49404, SAN FRANCISCO CA 94104